CSO Bruce Car resigns from Agios, effective July 31, 2022

AGIOS PHARMACEUTICALS, INC.

Bruce Car, Ph.D., Chief Scientific Officer, notified his resignation on May 15, 2022.
Resignation effective July 31, 2022; no replacement named as of filing date.
Voluntary departure; no reason or disagreement disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bruce Car

chief scientific officer

AGIO · AGIOS PHARMACEUTICALS, INC.

Effective: 2022-07-31
Filed: May 18, 2022, 7:59 PM ET

On May 15, 2022, Bruce Car, Ph.D. notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign as chief scientific officer of the Company, effective July 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Car resigned as chief scientific officer at AGIOS PHARMACEUTICALS, INC..

Action: resigned
Role: chief scientific officer

Exact text from the filing

On May 15, 2022, Bruce Car, Ph.D. notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign as chief scientific officer of the Company, effective July 31, 2022.

View on SEC.gov

AGIOS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-154024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.